/blog

Recent Posts

Hannah Loiacono

Hannah Loiacono is a director of public affairs at PhRMA, where she leads communications on PhRMA’s international priorities. Before joining PhRMA, she worked for a public affairs firm where she primarily supported health care related communications and research. Outside of the office, Hannah enjoys exploring Washington, D.C. with her dog Earl, attending concerts and cooking.

New analysis highlights access to new medicines in the United States and abroad

May 13, 2026

Trump Administration’s efforts to have other countries pay their fair share are underway

April 15, 2026

Leadership in biopharmaceutical R&D provides U.S. patients the greatest access to innovative medicines

March 11, 2026

Harmful U.S. policies will help drive China’s global leadership in biopharmaceutical innovation

March 4, 2026

Tariffs on medicines would harm American competitiveness, industry and patients

May 7, 2025

Experts discuss the value of IP at Senate Judiciary Committee hearing

May 28, 2024

International meetings hold big implications for Americans and our innovation ecosystem

February 26, 2024

New poll: Americans agree that expanding the TRIPS waiver will harm U.S. global manufacturing and innovation leadership

January 29, 2024

Arkansas puts patients first with new share the savings law

April 4, 2023

Tennessee’s Medicaid demonstration fails patients

February 1, 2021